首页 > 最新文献

Journal of lung, pulmonary & respiratory research最新文献

英文 中文
Re-expansion pulmonary edema after large left pleural effusion 大量左胸腔积液后再扩张肺水肿
Pub Date : 2021-03-09 DOI: 10.15406/jlprr.2021.08.00245
Bilal Chaudhry, MD, Kirill Alekseyev, MD, MBA, Lidiya Didenko MS, Nikita Donti, DO
Background: Reexpansion pulmonary edema (REPE) is a complication that arises from a precipitous or rapid expansion of a collapsed lung. This rare complication is thought to arise after using an intercostal drainage tube in patients with a tension pneumothorax, those with large pleural effusions, and occasionally when used therapeutically in thoracentesis. There are a multitude of risk factors, and it usually self-limiting, with the mainstay of treatment being supportive with oxygen. It is believed that 20% of cases are fatal. Case report: A 60-year-old male was treated with a 28 French tube for a large left pleural effusion. He developed REPE shortly after and developed severe shortness of breath, for which he required high flow oxygen. He was managed in the Intermediate Care Unit (IMCU) and shortly after was discharged home.
背景:再扩张性肺水肿(REPE)是由于肺萎陷时急剧或快速扩张引起的并发症。这种罕见的并发症被认为是在张力性气胸、大量胸腔积液患者使用肋间引流管后出现的,偶尔也会在胸腔穿刺治疗中使用。有许多危险因素,它通常是自我限制的,主要的治疗是支持氧气。据信,20%的病例是致命的。病例报告:一位60岁男性因大量左侧胸腔积液接受28法管治疗。不久之后,他出现了REPE,并出现了严重的呼吸短促,为此他需要高流量氧气。他在中级护理病房(IMCU)接受治疗,不久就出院回家了。
{"title":"Re-expansion pulmonary edema after large left pleural effusion","authors":"Bilal Chaudhry, MD, Kirill Alekseyev, MD, MBA, Lidiya Didenko MS, Nikita Donti, DO","doi":"10.15406/jlprr.2021.08.00245","DOIUrl":"https://doi.org/10.15406/jlprr.2021.08.00245","url":null,"abstract":"Background: Reexpansion pulmonary edema (REPE) is a complication that arises from a precipitous or rapid expansion of a collapsed lung. This rare complication is thought to arise after using an intercostal drainage tube in patients with a tension pneumothorax, those with large pleural effusions, and occasionally when used therapeutically in thoracentesis. There are a multitude of risk factors, and it usually self-limiting, with the mainstay of treatment being supportive with oxygen. It is believed that 20% of cases are fatal. Case report: A 60-year-old male was treated with a 28 French tube for a large left pleural effusion. He developed REPE shortly after and developed severe shortness of breath, for which he required high flow oxygen. He was managed in the Intermediate Care Unit (IMCU) and shortly after was discharged home.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84494592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antisynthetase Syndrome associated with mycobacterium tuberculosis infection, presenting as an acute respiratory failure 抗合成酶综合征与结核分枝杆菌感染有关,表现为急性呼吸衰竭
Pub Date : 2021-02-22 DOI: 10.15406/jlprr.2021.08.00243
A. B. Mansour, S. Ben Saad, S. Yaâlaoui, H. Bellali, H. Daghfous, F. Tritar
Antisynthetase syndrome (ASS) is characterized by myositis, interstitial lung disease, Raynaud’s phenomenon, fever and mechanics hands. Diagnosis is confirmed with the detection of an antibody directed against anti–aminoacyl–transfer–RNA synthetases (ARS). The most common anti–ARS antibody is anti–Jo–1. Opportunistic infections are common causes of mortality in patients with autoimmune diseases. Immunosuppressive treatment further contributes to the risk of infection. We report a rare case of a 68 year–old man diagnosed with antisynthetase syndrome associated to a pulmonary tuberculosis infection, revealed with an acute respiratory failure. The diagnosis of this rare combination of a connective tissue disease and tuberculosis revealed with an acute respiratory failure is difficult in a previously asymptomatic patient. Early diagnosis and immunosuppressive therapy associated to antituberculosis treatment started precociously prevented the disease progression and resulted in a good outcome.
抗合成酶综合征(ASS)以肌炎、肺间质性疾病、雷诺现象、发热和机械性手为特征。诊断是通过检测一种针对抗氨基酰基转移rna合成酶(ARS)的抗体来证实的。最常见的抗ars抗体是抗jo - 1。机会性感染是自身免疫性疾病患者死亡的常见原因。免疫抑制治疗进一步增加了感染的风险。我们报告一个罕见的病例68岁的男子诊断为抗合成酶综合征与肺结核感染,揭示了急性呼吸衰竭。这种罕见的结缔组织疾病和肺结核合并急性呼吸衰竭的诊断是困难的,在一个以前无症状的病人。早期诊断和免疫抑制治疗与抗结核治疗相关的早开始预防疾病进展并产生良好的结果。
{"title":"Antisynthetase Syndrome associated with mycobacterium tuberculosis infection, presenting as an acute respiratory failure","authors":"A. B. Mansour, S. Ben Saad, S. Yaâlaoui, H. Bellali, H. Daghfous, F. Tritar","doi":"10.15406/jlprr.2021.08.00243","DOIUrl":"https://doi.org/10.15406/jlprr.2021.08.00243","url":null,"abstract":"Antisynthetase syndrome (ASS) is characterized by myositis, interstitial lung disease, Raynaud’s phenomenon, fever and mechanics hands. Diagnosis is confirmed with the detection of an antibody directed against anti–aminoacyl–transfer–RNA synthetases (ARS). The most common anti–ARS antibody is anti–Jo–1. Opportunistic infections are common causes of mortality in patients with autoimmune diseases. Immunosuppressive treatment further contributes to the risk of infection. We report a rare case of a 68 year–old man diagnosed with antisynthetase syndrome associated to a pulmonary tuberculosis infection, revealed with an acute respiratory failure. The diagnosis of this rare combination of a connective tissue disease and tuberculosis revealed with an acute respiratory failure is difficult in a previously asymptomatic patient. Early diagnosis and immunosuppressive therapy associated to antituberculosis treatment started precociously prevented the disease progression and resulted in a good outcome.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87671999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Children: their role in the face of the pandemic in mexico 儿童:他们在墨西哥大流行病面前的作用
Pub Date : 2021-02-05 DOI: 10.15406/jlprr.2021.08.00241
MD. José de Jesús Coria Lorenzo, MD. Jorge Field Cortazares, Dr. Lauta Erika Garcia Carrillo
{"title":"Children: their role in the face of the pandemic in mexico","authors":"MD. José de Jesús Coria Lorenzo, MD. Jorge Field Cortazares, Dr. Lauta Erika Garcia Carrillo","doi":"10.15406/jlprr.2021.08.00241","DOIUrl":"https://doi.org/10.15406/jlprr.2021.08.00241","url":null,"abstract":"","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"110 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80330039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrapulmonary mature teratoma: case report of an exceptional entity 肺内成熟畸胎瘤:一例例外
Pub Date : 2021-02-05 DOI: 10.15406/jlprr.2021.08.00240
Najat Id el haj, S. Boubia, M. Ridai
Teratomas are tumors consisting of tissues derived from more than one germ cell line. Criteria for pulmonary origin are exclusion of a gonadal or other extra-gonadal primary site and origin entirely within the lung. The intrapulmonary teratoma (IPT) is a rare type of teratoma extra-gonadal which often presents with nonspecific symptoms and wrongly can be diagnosed as other diseases. Here we report a patient with IPT who was initially misdiagnosed as pulmonary aspergilloma. We report a case of mature pulmonary teratoma in a 22-year-old male with no toxic habits, treated in 2007 for smear-positive pulmonary tuberculosis, presenting progressively for 1 year, with a left chest pain, intermittent episodes of cough and hemoptysis, and dyspnea. A computed tomography (CT) chest scan showed a heterogeneous tumor with cavitary lesion in the left upper lobe. The patient had a left upper lobectomy with complete resection of the mediastinal mass. The patient is currently in good general condition, and does not present any complications or recurrence and thyroid function was normal during the long term follow up. Preoperative diagnosis of IPT is not always possible and is usually misdiagnosed early on due to its rarity, nonspecific and vague symptoms, normal lab results, and indistinguishable chest x-ray results. We report a case of intrapulmonary teratoma in a 22-year-old man and review the relevant literature.
畸胎瘤是由一种以上生殖细胞系的组织组成的肿瘤。肺起源的标准是排除性腺或其他性腺外原发部位和完全在肺内起源。肺内畸胎瘤(IPT)是一种罕见的性腺外畸胎瘤,常表现为非特异性症状,可误诊为其他疾病。在此,我们报告一位最初被误诊为肺曲菌瘤的IPT患者。我们报告一例成熟的肺畸胎瘤,22岁男性,无不良习惯,2007年因涂片阳性肺结核接受治疗,进行性表现为1年,左胸痛,间歇性咳嗽和咯血,呼吸困难。胸部电脑断层扫描显示一非均匀肿瘤并在左上叶有空洞病变。患者行左侧上肺叶切除术,并完全切除纵隔肿块。患者目前总体情况良好,长期随访无并发症及复发,甲状腺功能正常。IPT的术前诊断并不总是可能的,并且由于其罕见,非特异性和模糊的症状,正常的实验室结果和难以区分的胸片结果,通常在早期被误诊。我们报告一例22岁男性肺内畸胎瘤,并回顾相关文献。
{"title":"Intrapulmonary mature teratoma: case report of an exceptional entity","authors":"Najat Id el haj, S. Boubia, M. Ridai","doi":"10.15406/jlprr.2021.08.00240","DOIUrl":"https://doi.org/10.15406/jlprr.2021.08.00240","url":null,"abstract":"Teratomas are tumors consisting of tissues derived from more than one germ cell line. Criteria for pulmonary origin are exclusion of a gonadal or other extra-gonadal primary site and origin entirely within the lung. The intrapulmonary teratoma (IPT) is a rare type of teratoma extra-gonadal which often presents with nonspecific symptoms and wrongly can be diagnosed as other diseases. Here we report a patient with IPT who was initially misdiagnosed as pulmonary aspergilloma. We report a case of mature pulmonary teratoma in a 22-year-old male with no toxic habits, treated in 2007 for smear-positive pulmonary tuberculosis, presenting progressively for 1 year, with a left chest pain, intermittent episodes of cough and hemoptysis, and dyspnea. A computed tomography (CT) chest scan showed a heterogeneous tumor with cavitary lesion in the left upper lobe. The patient had a left upper lobectomy with complete resection of the mediastinal mass. The patient is currently in good general condition, and does not present any complications or recurrence and thyroid function was normal during the long term follow up. Preoperative diagnosis of IPT is not always possible and is usually misdiagnosed early on due to its rarity, nonspecific and vague symptoms, normal lab results, and indistinguishable chest x-ray results. We report a case of intrapulmonary teratoma in a 22-year-old man and review the relevant literature.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83264268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research. 血管紧张素转换酶-2 (ACE-2)在疾病中的作用及其研究前景。
Pub Date : 2021-01-01 Epub Date: 2021-05-03
Amal Abdul-Hafez, Tarek Mohamed, Bruce D Uhal

Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Like the 2002-2003 epidemic severe acute respiratory syndrome coronavirus (SARS-CoV), angiotensin converting enzyme-2 (ACE-2) has been identified as the SARS-CoV-2 receptor.1-3 The virus docks into host cell via its spike protein binding to ACE-2 and undergoes proteolytic cleavage by TMPRSS2 protease to facilitate membrane fusion. The spike protein binding to ACE-2 has been shown to be stronger in the novel SARS-CoV-2 virus.1 This review will present an overview of ACE-2 biology.

2019冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的。与2002-2003年流行的严重急性呼吸综合征冠状病毒(SARS-CoV)一样,血管紧张素转换酶-2 (ACE-2)已被确定为SARS-CoV-2受体。1-3病毒通过其刺突蛋白与ACE-2结合进入宿主细胞,并通过TMPRSS2蛋白酶进行蛋白水解裂解以促进膜融合。与ACE-2结合的刺突蛋白已被证明在新型SARS-CoV-2病毒中更强这篇综述将介绍ACE-2生物学的概况。
{"title":"Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research.","authors":"Amal Abdul-Hafez,&nbsp;Tarek Mohamed,&nbsp;Bruce D Uhal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Coronavirus Disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Like the 2002-2003 epidemic severe acute respiratory syndrome coronavirus (SARS-CoV), angiotensin converting enzyme-2 (ACE-2) has been identified as the SARS-CoV-2 receptor.<sup>1-3</sup> The virus docks into host cell via its spike protein binding to ACE-2 and undergoes proteolytic cleavage by TMPRSS2 protease to facilitate membrane fusion. The spike protein binding to ACE-2 has been shown to be stronger in the novel SARS-CoV-2 virus.<sup>1</sup> This review will present an overview of ACE-2 biology.</p>","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"8 2","pages":"54-60"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39328472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulation of ACE-2 enzyme by hyperoxia in lung epithelial cells by post-translational modification. 翻译后修饰对肺上皮细胞高氧对ACE-2酶的调控
Pub Date : 2021-01-01 Epub Date: 2021-05-06
Tarek Mohamed, Amal Abdul-Hafez, Bruce D Uhal

Background: Bronchopulmonary Dysplasia (BPD) occurs in premature neonates with respiratory distress who require supplemental oxygen in the first days after birth. BPD involves uniform arrest of alveolar development and variable interstitial cellularity and/or fibroproliferation. Previous studies by our lab showed that the enzyme, angiotensin converting enzyme-2 (ACE-2) and its product Ang1-7 exerting action on the receptor Mas oncogene in what is known as ACE-2/Mas axis is protective to lung cells. We also showed that ACE-2 is expressed in fetal human lung fibroblasts but is significantly decreased by hyperoxic gas lung injury, an effect caused by ACE-2 enzyme shedding mediated by TNF-alpha-converting enzyme (TACE/ADAM17). However, no reports yet exist about the regulation of ACE-2 in the alveolar epithelia in hyperoxic lung injury.

Objective: In this study we aim to define the effects of hyperoxic lung injury on the protective ACE-2 enzyme in the human lung alveolar epithelial cell line A549.

Design/methods: Cultured A549 cells were exposed to hyperoxia (95% O2) or normoxia (21% O2) for 3 or 7 days in serum-free nutrient media. Cells were lysed and culture media were collected to test for cellular ACE-2 enzymatic activity and for ACE-2, Mas receptor, TACE/ADAM17, and ubiquitin proteins abundance by immunoblotting. Cells were harvested in Trizol for RNA extraction and ACE-2 qRT-PCR. Whole cell extracts of A549 cell line was used for ACE-2 immunoprecipitation and subsequent ubiquitin immunoblotting.

Results: Total ubiquitinated proteins were increased by hyperoxia treatment, while ACE-2 and Mas receptor proteins abundance and ACE-2 enzymatic activity were decreased significantly in A549 cells exposed to hyperoxia relative to the normoxia controls. The percent decrease in ACE-2 activity corresponded with increased time of hyperoxic gas exposure. However, in contrast to our data from lung fibroblasts, no significant change was noted in ACE-2 protein released into the media or in ACE-2 mRNA levels by the hyperoxic treatment. Ubiquitin immunoreactive bands were detectable in the ACE-2 immunoprecipitate.

Conclusions: These data suggest that hyperoxic exposure of the lung epithelial cells decreases the protective enzyme ACE-2 by cell type specific mechanisms independent of shedding by TACE/ADAM17. The data also suggest a regulatory level of ACE-2 downstream of transcription may involve ACE-2 ubiquitination and targeting for degradation.

背景:支气管肺发育不良(BPD)发生在呼吸窘迫的早产儿中,在出生后的第一天需要补充氧气。BPD包括肺泡发育的均匀阻滞和间质细胞和/或纤维增生的变化。我们实验室之前的研究表明,血管紧张素转换酶-2 (ACE-2)及其产物Ang1-7作用于受体Mas癌基因,即ACE-2/Mas轴,对肺细胞具有保护作用。我们还发现,ACE-2在胎儿人肺成纤维细胞中表达,但在高氧气体肺损伤时显著降低,这是由tnf - α转换酶(TACE/ADAM17)介导的ACE-2酶脱落引起的。然而,关于ACE-2在高氧肺损伤中对肺泡上皮的调控尚无报道。目的:研究高氧肺损伤对人肺泡上皮细胞系A549保护性ACE-2酶的影响。设计/方法:培养的A549细胞在无血清营养培养基中暴露于高氧(95% O2)或常氧(21% O2)中3天或7天。裂解细胞,收集培养基,免疫印迹法检测细胞ACE-2酶活性,检测ACE-2、Mas受体、TACE/ADAM17和泛素蛋白丰度。在Trizol中收集细胞进行RNA提取和ACE-2 qRT-PCR。采用A549细胞株全细胞提取物进行ACE-2免疫沉淀和泛素免疫印迹。结果:高氧处理使A549细胞的泛素化蛋白总量增加,而ACE-2和Mas受体蛋白丰度和ACE-2酶活性明显低于正常氧条件下的对照组。ACE-2活性的下降百分比与高氧气体暴露时间的增加相对应。然而,与我们从肺成纤维细胞获得的数据相反,高氧处理没有发现释放到培养基中的ACE-2蛋白或ACE-2 mRNA水平的显著变化。在ACE-2免疫沉淀物中检测到泛素免疫反应带。结论:这些数据表明,肺上皮细胞的高氧暴露通过独立于TACE/ADAM17脱落的细胞类型特异性机制降低了保护酶ACE-2。这些数据还表明,转录下游的ACE-2调控水平可能涉及ACE-2泛素化和靶向降解。
{"title":"Regulation of ACE-2 enzyme by hyperoxia in lung epithelial cells by post-translational modification.","authors":"Tarek Mohamed,&nbsp;Amal Abdul-Hafez,&nbsp;Bruce D Uhal","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Bronchopulmonary Dysplasia (BPD) occurs in premature neonates with respiratory distress who require supplemental oxygen in the first days after birth. BPD involves uniform arrest of alveolar development and variable interstitial cellularity and/or fibroproliferation. Previous studies by our lab showed that the enzyme, angiotensin converting enzyme-2 (ACE-2) and its product Ang1-7 exerting action on the receptor Mas oncogene in what is known as ACE-2/Mas axis is protective to lung cells. We also showed that ACE-2 is expressed in fetal human lung fibroblasts but is significantly decreased by hyperoxic gas lung injury, an effect caused by ACE-2 enzyme shedding mediated by TNF-alpha-converting enzyme (TACE/ADAM17). However, no reports yet exist about the regulation of ACE-2 in the alveolar epithelia in hyperoxic lung injury.</p><p><strong>Objective: </strong>In this study we aim to define the effects of hyperoxic lung injury on the protective ACE-2 enzyme in the human lung alveolar epithelial cell line A549.</p><p><strong>Design/methods: </strong>Cultured A549 cells were exposed to hyperoxia (95% O2) or normoxia (21% O2) for 3 or 7 days in serum-free nutrient media. Cells were lysed and culture media were collected to test for cellular ACE-2 enzymatic activity and for ACE-2, Mas receptor, TACE/ADAM17, and ubiquitin proteins abundance by immunoblotting. Cells were harvested in Trizol for RNA extraction and ACE-2 qRT-PCR. Whole cell extracts of A549 cell line was used for ACE-2 immunoprecipitation and subsequent ubiquitin immunoblotting.</p><p><strong>Results: </strong>Total ubiquitinated proteins were increased by hyperoxia treatment, while ACE-2 and Mas receptor proteins abundance and ACE-2 enzymatic activity were decreased significantly in A549 cells exposed to hyperoxia relative to the normoxia controls. The percent decrease in ACE-2 activity corresponded with increased time of hyperoxic gas exposure. However, in contrast to our data from lung fibroblasts, no significant change was noted in ACE-2 protein released into the media or in ACE-2 mRNA levels by the hyperoxic treatment. Ubiquitin immunoreactive bands were detectable in the ACE-2 immunoprecipitate.</p><p><strong>Conclusions: </strong>These data suggest that hyperoxic exposure of the lung epithelial cells decreases the protective enzyme ACE-2 by cell type specific mechanisms independent of shedding by TACE/ADAM17. The data also suggest a regulatory level of ACE-2 downstream of transcription may involve ACE-2 ubiquitination and targeting for degradation.</p>","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"8 ","pages":"47-52"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39913275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization of pulmonary rehabilitation for everyone 人人都能利用肺部康复
Pub Date : 2021-01-01 DOI: 10.15406/jlprr.2021.08.00244
K. McCain
Knowledge and therapy for patients with respiratory illnesses has been ongoing in the medical world. Assisting with the patient’s quality of life and possible recovery is a type of rehab that includes education as well as monitored exercise. This rehab notably labeled Pulmonary Rehab is managed by healthcare workers with the intent on assisting the patient to not only get up and move, but to remain social. Quarantine and the threat of being infected with Covid-19 put a halt to programs like this. As people were searching for ways to see their physicians for appointments and telehealth was approved for most, it was not for Pulmonary Rehab. These patients that had been placed in a program to ensure they would have interaction, were now just shut in their homes. Pulmonary Rehab should be open to all not being approved now because of insurance or other details such as financial or telehealth issues.
医学界对呼吸系统疾病患者的认识和治疗一直在进行中。帮助病人提高生活质量和可能的康复是一种康复,包括教育和监测运动。这种康复治疗是由医护人员管理的,目的是帮助病人不仅站起来和移动,而且保持社交。隔离和感染Covid-19的威胁使这样的项目停止了。当人们在寻找方法去看医生预约时,远程医疗得到了大多数人的批准,但这并不适用于肺康复。这些病人被安排在一个项目中,以确保他们能有互动,现在他们被关在家里。肺康复应该向所有因保险或其他细节(如财务或远程医疗问题)而未获批准的人开放。
{"title":"Utilization of pulmonary rehabilitation for everyone","authors":"K. McCain","doi":"10.15406/jlprr.2021.08.00244","DOIUrl":"https://doi.org/10.15406/jlprr.2021.08.00244","url":null,"abstract":"Knowledge and therapy for patients with respiratory illnesses has been ongoing in the medical world. Assisting with the patient’s quality of life and possible recovery is a type of rehab that includes education as well as monitored exercise. This rehab notably labeled Pulmonary Rehab is managed by healthcare workers with the intent on assisting the patient to not only get up and move, but to remain social. Quarantine and the threat of being infected with Covid-19 put a halt to programs like this. As people were searching for ways to see their physicians for appointments and telehealth was approved for most, it was not for Pulmonary Rehab. These patients that had been placed in a program to ensure they would have interaction, were now just shut in their homes. Pulmonary Rehab should be open to all not being approved now because of insurance or other details such as financial or telehealth issues.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87408584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation 全氟丙烷心肺耐受性的增强MRI肺通气
Pub Date : 2020-12-30 DOI: 10.15406/jlprr.2020.07.00239
Joseph Mammarappallil, MD, PhD, Richard E. Moon MD, Neil R. MacIntyre MD, W. M. Foster PhD, Samantha J. Womack MS, Maureen D. Ainslie MS RT(R)MR, H. P. McAdams, MD, Ahmed F. Halaweish PhD, Kingshuk Choudury PhD, H. C. Charles PhD
Rationale: Recent advances in perfluoropropane magnetic resonance imaging of the lung have provided the means to assess pulmonary ventilation and gas distribution throughout the pulmonary airways and acini in a non-invasive manner. Objectives: The increased density of the inhaled PFP/O2 gas mixture generates longer wash-in times compared to wash-out while breathing room air and leads to slight increases in airway resistance (Raw) and respiratory effort by the subject during imaging. As a consequence of these gas-related effects, we sought to evaluate the cardio-respiratory tolerability of the PFP/O2 gas mixtures in our sequential breath-hold imaging protocol in normal subjects and subjects with obstructive lung disease. Methods: Tolerability was determined by evaluation of changes in vital signs (Heart Rate, Systolic and Diastolic Blood Pressure, Respiratory Rate and Temperature (otic)) at 3 time points (screening, pre-imaging and post-imaging) Measurements and Main Results: Assessment of vital signs before and after the administration of perfluoropropane gas mixture by matched pair analysis demonstrated statistically different values for Heart rate (Mean Difference =-2.417 bpm), Systolic BP (Mean Difference=6.95 mmHg), Diastolic BP (Mean Difference=3.86 mmHg) and SpO2 (Mean Difference=0.56%) even though these do not represent physiologically significant differences compared to activities of daily living such as climbing a flight of stairs. Conclusions: Our data demonstrate no negative outcomes in using PFP gas to image pulmonary ventilation. The PFP gas mixture is safe, well tolerated, and provides a three dimensional ‘picture’ (representation) of inhaled gas distribution for subject cohorts of normal and obstructive lung disease.
原理:全氟丙烷肺磁共振成像的最新进展提供了以无创方式评估肺通气和整个肺气道和腺泡气体分布的手段。目的:吸入PFP/O2气体混合物的密度增加,与呼吸室内空气时的冲洗时间相比,会产生更长的冲洗时间,并导致受试者在成像期间气道阻力(Raw)和呼吸力的轻微增加。由于这些气体相关的影响,我们试图在我们的顺序屏气成像方案中评估正常受试者和阻塞性肺疾病受试者的PFP/O2气体混合物的心肺耐受性。方法:通过3个时间点(筛查、显像前和显像后)测量的生命体征(心率、收缩压、舒张压、呼吸频率和体温)的变化来确定耐受性。通过配对分析对全氟丙烷气体混合物使用前后的生命体征进行评估,结果显示心率(平均差值=-2.417 bpm)、收缩压(平均差值=6.95 mmHg)、舒张压(平均差值=3.86 mmHg)和SpO2(平均差值=0.56%)在统计学上存在差异,尽管与爬楼梯等日常生活活动相比,这些并不代表生理上的显著差异。结论:我们的数据表明使用PFP气体成像肺通气没有负面结果。PFP气体混合物是安全的,耐受性良好,并为正常和阻塞性肺部疾病的受试者队列提供了吸入气体分布的三维“图像”(表示)。
{"title":"Cardio-Respiratory tolerability of perfluoropropaneEnhanced MRI of pulmonary ventilation","authors":"Joseph Mammarappallil, MD, PhD, Richard E. Moon MD, Neil R. MacIntyre MD, W. M. Foster PhD, Samantha J. Womack MS, Maureen D. Ainslie MS RT(R)MR, H. P. McAdams, MD, Ahmed F. Halaweish PhD, Kingshuk Choudury PhD, H. C. Charles PhD","doi":"10.15406/jlprr.2020.07.00239","DOIUrl":"https://doi.org/10.15406/jlprr.2020.07.00239","url":null,"abstract":"Rationale: Recent advances in perfluoropropane magnetic resonance imaging of the lung have provided the means to assess pulmonary ventilation and gas distribution throughout the pulmonary airways and acini in a non-invasive manner. Objectives: The increased density of the inhaled PFP/O2 gas mixture generates longer wash-in times compared to wash-out while breathing room air and leads to slight increases in airway resistance (Raw) and respiratory effort by the subject during imaging. As a consequence of these gas-related effects, we sought to evaluate the cardio-respiratory tolerability of the PFP/O2 gas mixtures in our sequential breath-hold imaging protocol in normal subjects and subjects with obstructive lung disease. Methods: Tolerability was determined by evaluation of changes in vital signs (Heart Rate, Systolic and Diastolic Blood Pressure, Respiratory Rate and Temperature (otic)) at 3 time points (screening, pre-imaging and post-imaging) Measurements and Main Results: Assessment of vital signs before and after the administration of perfluoropropane gas mixture by matched pair analysis demonstrated statistically different values for Heart rate (Mean Difference =-2.417 bpm), Systolic BP (Mean Difference=6.95 mmHg), Diastolic BP (Mean Difference=3.86 mmHg) and SpO2 (Mean Difference=0.56%) even though these do not represent physiologically significant differences compared to activities of daily living such as climbing a flight of stairs. Conclusions: Our data demonstrate no negative outcomes in using PFP gas to image pulmonary ventilation. The PFP gas mixture is safe, well tolerated, and provides a three dimensional ‘picture’ (representation) of inhaled gas distribution for subject cohorts of normal and obstructive lung disease.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"2004 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89518120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Airway epithelial dysfunction contributes to the pathogenesis of asthma 气道上皮功能障碍参与哮喘的发病机制
Pub Date : 2020-12-07 DOI: 10.15406/jlprr.2020.07.00238
N. Syabbalo
growth factor (VEGF), angiopoietin, and angiogenin in the airways, which promote neovascularization, expansion of the airway vascular bed, oedema, and airway narrowing. 19 These changes are inevitably associated with thickening and shedding of the airway epithelium in both atopic and non-atopic asthmatic patients. 20,21 Additionally, there is goblet cell, and submucous gland hyperplasia resulting in mucus hypersecretion. 22 This is accompanied by hyperplasia and hypertrophy of ASM cells, which acquire a highly proliferative, secretory, and contractile phenotype. 15,18,22 These structural changes are associated with more severe fixed airflow obstruction, which may be unresponsive to high dose inhaled corticosteroids (ICS), and to
气道中的生长因子(VEGF)、血管生成素和血管生成素,它们促进新生血管形成、气道血管床扩张、水肿和气道狭窄。这些变化不可避免地与特应性和非特应性哮喘患者气道上皮的增厚和脱落有关。20,21此外,还有杯状细胞和粘膜下腺增生,导致粘液分泌过多。这伴随着ASM细胞的增生和肥大,ASM细胞具有高度增殖、分泌和收缩的表型。15,18,22这些结构变化与更严重的固定气流阻塞有关,这可能对高剂量吸入皮质类固醇(ICS)无反应
{"title":"Airway epithelial dysfunction contributes to the pathogenesis of asthma","authors":"N. Syabbalo","doi":"10.15406/jlprr.2020.07.00238","DOIUrl":"https://doi.org/10.15406/jlprr.2020.07.00238","url":null,"abstract":"growth factor (VEGF), angiopoietin, and angiogenin in the airways, which promote neovascularization, expansion of the airway vascular bed, oedema, and airway narrowing. 19 These changes are inevitably associated with thickening and shedding of the airway epithelium in both atopic and non-atopic asthmatic patients. 20,21 Additionally, there is goblet cell, and submucous gland hyperplasia resulting in mucus hypersecretion. 22 This is accompanied by hyperplasia and hypertrophy of ASM cells, which acquire a highly proliferative, secretory, and contractile phenotype. 15,18,22 These structural changes are associated with more severe fixed airflow obstruction, which may be unresponsive to high dose inhaled corticosteroids (ICS), and to","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87611307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Lung sensors in pulmonary diseases 肺部疾病中的肺部传感器
Pub Date : 2020-11-30 DOI: 10.15406/jlprr.2020.07.00237
Jerome Walker, Jerry Yu
Sensory information in the lung is mainly generated by airway sensors carried by the vagus nerves, yielding multiple reflex responses essential for breathing control and lung defense. When these sensors are activated in lung disease, they produce clinical signs, including cough, bronchoconstriction and mucus secretion, and alter disease course by reflexes and neuroimmune interaction.
肺中的感觉信息主要由迷走神经携带的气道传感器产生,产生多种反射反应,对呼吸控制和肺防御至关重要。当这些传感器在肺部疾病中被激活时,它们产生临床症状,包括咳嗽、支气管收缩和粘液分泌,并通过反射和神经免疫相互作用改变病程。
{"title":"Lung sensors in pulmonary diseases","authors":"Jerome Walker, Jerry Yu","doi":"10.15406/jlprr.2020.07.00237","DOIUrl":"https://doi.org/10.15406/jlprr.2020.07.00237","url":null,"abstract":"Sensory information in the lung is mainly generated by airway sensors carried by the vagus nerves, yielding multiple reflex responses essential for breathing control and lung defense. When these sensors are activated in lung disease, they produce clinical signs, including cough, bronchoconstriction and mucus secretion, and alter disease course by reflexes and neuroimmune interaction.","PeriodicalId":91750,"journal":{"name":"Journal of lung, pulmonary & respiratory research","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88258031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of lung, pulmonary & respiratory research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1